Mapping the Global Diabetes Epidemic — 2025 Health Data Visualization

From insulin access to obesity rates — these maps trace the uneven geography of diabetes in 2025.

🌍 Mapping the Global Diabetes Epidemic — 2025

Global diabetes data visualization header

Diabetes has become one of the defining health challenges of our era — quietly reshaping lives, economies, and healthcare systems. Behind each statistic lies a person measuring, injecting, adapting. Yet on a world map, the patterns tell a larger story — one of inequality, urbanization, and medical access. Using MAPTHOS visualizations, we explore how this condition manifests globally in 2025.


🧬 Where the Disease Spreads Most

Global diabetes prevalence map 2025

This world map shows diabetes prevalence (% of adult population) by country. The Middle East, North America, and parts of Southeast Asia report the highest rates — above 15% in some nations. In contrast, sub-Saharan Africa remains relatively low but rapidly rising. Urban diets, processed food, and sedentary lifestyles create a common risk landscape — regardless of income level.


⚖️ The Weight of Modern Life

Global overweight and obesity rates map Overweight and obesity rates correlate almost perfectly with diabetes prevalence. In countries like Mexico, Saudi Arabia, and the U.S., over 70% of adults are overweight. Europe’s north–south divide is also visible: Nordic nations fare better, while Mediterranean countries show growing rates among youth. MAPTHOS heatmaps make it easy to compare obesity and diabetes side by side — revealing how prevention could start far earlier than diagnosis.

💉 Access to Insulin: A Global Inequality

Global insulin access map 2025

Insulin, discovered over a century ago, remains a luxury in many parts of the world. In low-income countries, supply chains and pricing make consistent access difficult. The darker zones on this map mark regions where less than 40% of diabetics have reliable access to insulin. Even in middle-income nations, cost can equal several days of wages per month.


💰 The Price of Survival

Insulin price comparison map

The average monthly cost of insulin varies dramatically — from under $10 in parts of Europe to over $100 in the U.S. or some Asian markets. For millions, this means rationing doses or skipping treatment entirely. Visualizing these differences reminds us: healthcare economics isn’t abstract — it’s measured in milligrams and missed doses.


🩺 The Human Factor: Endocrinologists per Population

Map of endocrinologists per population

Access to specialized care determines outcomes as much as medication. This map shows the number of endocrinologists per 100,000 people. Western Europe and Japan lead; many African and South Asian countries have fewer than one specialist per million inhabitants. It’s not just about drugs — it’s about systems, expertise, and education.


⚰️ Mortality and Missed Prevention

Global diabetes mortality map

Despite medical advances, diabetes-related deaths continue to rise — surpassing 6.7 million globally in 2025. The pattern mirrors socioeconomic lines: where healthcare and nutrition intersect with poverty. Each point on this map is more than data — it’s a call to strengthen prevention and public health.


🌐 Why Mapping Matters

By layering these datasets in MAPTHOS — prevalence, obesity, insulin access, cost, and medical infrastructure — we see not one epidemic but many overlapping ones. Geography shapes biology. Policy shapes survival.

As AI-powered mapping evolves, visualizing health inequities becomes a tool not just for awareness but for action.

👉 Explore more at app.mapthos.org

See the world. Map better. Dream big. 🌍✨

Ready to explore world data?

Launch App

Follow MAPTHOS